Rehydration Therapeutics

BiotechnologyAngelShanghai, Chinarehydrationtx.com

Latest round

Angel

Last raised

May 2026

Total raised

Undisclosed

Investors

2

About Rehydration Therapeutics

, dba Rehydration Therapeutics, is a biotechnology company focusing on small nucleic acid therapeutics with an emphasis on extrahepatic tissue-specific targeted delivery and treatment. The company was jointly established by Professor Chuan Zhang from Shanghai Jiao Tong University and Professor Jiaxu Hong from the Eye & ENT Hospital of Fudan University. Rehydration Therapeutics works with the medical research sector to provide nucleic acid drugs, utilizing novel nucleic acid modifications to treat dry eye, corneal dystrophy, thyroid-associated ophthalmopathy (TAO), uveitis and macular degeneration. The company has built an AI (artificial intelligence) assisted and nucleic acid modification-based platform for screening extrahepatic targeting molecule, and also a platform for constructing nucleic acid inhibitor targeting specific proteins.

Who invested in Rehydration Therapeutics

2 investors across 1 round

See all investors in Rehydration Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Angel

    May 9, 2026

    Amount

    Undisclosed

    Investors

    Locked

Questions about Rehydration Therapeutics

Who invested in Rehydration Therapeutics?

Rehydration Therapeutics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Rehydration Therapeutics raised?

Rehydration Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Rehydration Therapeutics last raise money?

Rehydration Therapeutics's most recent round on record is a Angel, in May 2026.

What does Rehydration Therapeutics do?

, dba Rehydration Therapeutics, is a biotechnology company focusing on small nucleic acid therapeutics with an emphasis on extrahepatic tissue-specific targeted delivery and treatment.

Where is Rehydration Therapeutics headquartered?

Rehydration Therapeutics is headquartered in Shanghai, China.

Which VCs invest in companies like Rehydration Therapeutics?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Rehydration Therapeutics's stage. Their profiles are linked below.

Raising like Rehydration Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.